Membrane current recordings were performed at 21–25°C, 16–72 h after proteoliposome injection, using a high compliance two-microelectrode voltage-clamp system (TurboTEC-10CD, npi Tamm, Germany). The recording methodology has been described previously (Morales et al., 1995; Alberola-Die et al., 2016). Briefly, oocytes were placed in a 150 μl recording chamber and continuously superfused with normal frog Ringer’s solution (NR: 115 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 5 mM HEPES, pH 7.0) supplemented with 0.5 μM atropine sulfate (ANR) to block any muscarinic response (Kusano et al., 1982). The membrane potential was held at -60 mV, unless otherwise stated. ACh and other tested drugs were diluted in ANR solution and oocytes were superfused with them at a flow rate of 13–17 ml min-1. Membrane currents elicited by ACh (IACh) either alone or co-applied with DMA, were low-pass filtered at 30–1000 Hz and, after sampling at fivefold the filter frequency (Digidata series 1200 and 1440A; Axon Instruments, Foster City, CA, USA), recorded on two PC-computers, using the WCP v. 3.2.8 package developed by J. Dempster (Strathclyde Electrophysiology Software, University of Strathclyde, Scotland, UK) and AxoScope v. 10.0.0.60 (Molecular Devices Corporation, Sunnyvale, CA, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.